PT Medikaloka Hermina Tbk (IDX:HEAL)
635.00
-20.00 (-3.05%)
Sep 22, 2026, 3:20 PM WIB
PT Medikaloka Hermina Tbk Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, PT Medikaloka Hermina Tbk stock has a consensus rating of "Buy" and an average price target of Rp 1,338. The average 1-year stock price forecast is 110.74% higher than the current stock price, while the lowest is Rp 840.00 (+32.28%) and the highest is Rp 1,800 (+183.46%).
Price Target: Rp 1,338 (+110.74%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PT Medikaloka Hermina Tbk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 5 | 7 | 8 | 8 | 8 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 13 | 14 | 14 | 14 |
Financial Forecast
Revenue This Year
7.75T
from 7.13T
Increased by 8.65%
Revenue Next Year
8.50T
from 7.75T
Increased by 9.72%
EPS This Year
30.21
from 28.40
Increased by 6.36%
EPS Next Year
37.45
from 30.21
Increased by 24.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is IDR.